These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 3533723)
1. [Study of promutagen biotransformation in the Ames test. IV. The effect of transplanted tumors on the biotransformation of various antineoplastic agents]. Oblapenko NG; Loknitskaia NN; Presnova ZhF; Chernov VA; Fonshteĭn LM Genetika; 1986 Sep; 22(9):2265-71. PubMed ID: 3533723 [TBL] [Abstract][Full Text] [Related]
2. [Study of the biotransformation of various antineoplastic agents using the Ames test]. Oblapenko NG; Prikhod'ko AZ; Fonshteĭn LM; Chernov VA Eksp Onkol; 1988; 10(5):52-5. PubMed ID: 3061779 [TBL] [Abstract][Full Text] [Related]
3. [Study of the process of promutagen biotransformation by the Ames test. I. The role of conjugation with glutathione in the modification of the mutagenic activity of nitrosomorpholine, diethylnitrosamine and cyclophosphamide]. Fonshteĭn LM; Loknitskaia NN; Rotenberg IuS Genetika; 1985 Nov; 21(11):1821-7. PubMed ID: 3908219 [TBL] [Abstract][Full Text] [Related]
4. [Study of promutagen biotransformation in the Ames test. III. The role of conjugation with glucuronic acid and sulfate in the modification of mutagenic effect of nitrosomorpholine, diethylnitrosamine and cyclophosphamide]. Loknitskaia NN; Rotenberg IuS; Fonshteĭn LM; Shuliakovskaia TS Genetika; 1986 Sep; 22(9):2259-64. PubMed ID: 3533722 [TBL] [Abstract][Full Text] [Related]
5. [The process of promutagen biotransformation studied by the Ames test. II. The extent of the manifestation of the mutagenic action of nitrosomorpholine, diethylnitrosamine and cyclophosphane using various subfractions of rat liver homogenate]. Loknitskaia NN; Fonshteĭn LM Genetika; 1985 Dec; 21(12):1932-6. PubMed ID: 4085789 [TBL] [Abstract][Full Text] [Related]
6. [Butylhydroxytoluene inhibition of the mutagenic activity of carcinogenic nitroso compounds and cyclophosphamide: the role of the glutathione conjugation reaction]. Kalinina EV; Loknitskaia NN; Shuliakovskaia TS; Fonshteĭn LM Vopr Onkol; 1987; 33(9):59-63. PubMed ID: 3310399 [TBL] [Abstract][Full Text] [Related]
7. [Ames test study of the effect of 2nd-phase biotransformation reactions on the level of mutagenic action of a number of chemical compounds]. Loknitskaia NN; Fonshteĭn LM Tsitol Genet; 1988; 22(3):43-6. PubMed ID: 3142125 [TBL] [Abstract][Full Text] [Related]
8. [Modifying action of drug preparations on the effect of promutagen compounds]. Oblapenko NG; Fonshteĭn LM Tsitol Genet; 1987; 21(2):118-22. PubMed ID: 3296365 [TBL] [Abstract][Full Text] [Related]
9. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds. Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387 [TBL] [Abstract][Full Text] [Related]
10. In vitro biotransformation and genotoxicity of the drinking water disinfection byproduct bromodichloromethane: DNA binding mediated by glutathione transferase theta 1-1. Ross MK; Pegram RA Toxicol Appl Pharmacol; 2004 Mar; 195(2):166-81. PubMed ID: 14998683 [TBL] [Abstract][Full Text] [Related]
11. Mutagenicity experiments on agroclavines, new natural antineoplastic compounds. Glatt H; Eich E; Pertz H; Becker C; Oesch F Cancer Res; 1987 Apr; 47(7):1811-4. PubMed ID: 3545454 [TBL] [Abstract][Full Text] [Related]
12. Multi-walled carbon nanotubes: Lack of mutagenic activity in the bacterial reverse mutation assay. Di Sotto A; Chiaretti M; Carru GA; Bellucci S; Mazzanti G Toxicol Lett; 2009 Feb; 184(3):192-7. PubMed ID: 19063954 [TBL] [Abstract][Full Text] [Related]
13. [The role of UDP glucuronosyl- and sulfotransferases in the butylhydroxytoluene suppression of the mutagenic action of carcinogenic nitroso compounds and cyclophosphane]. Kalinina EV; Loknitskaia NN; Shuliakovskaia TS; Fonshteĭn LM Vopr Onkol; 1989; 35(2):220-5. PubMed ID: 2494809 [TBL] [Abstract][Full Text] [Related]
14. Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochromes P-450. Hales BF Teratology; 1981 Aug; 24(1):1-11. PubMed ID: 7029774 [TBL] [Abstract][Full Text] [Related]
15. [Mutagenic activity of 2,4,6-trinitrotoluene: the role of metabolizing enzymes]. Karamova NS; Il'inskaia ON; Ivanchenko OB Genetika; 1994 Jul; 30(7):898-902. PubMed ID: 7958804 [TBL] [Abstract][Full Text] [Related]
16. Biochemical and biological properties of prospective N-nitrodialkylamine metabolites and their derivatives. Frei E; Pool BL; Plesch W; Wiessler M IARC Sci Publ; 1984; (57):491-7. PubMed ID: 6398301 [TBL] [Abstract][Full Text] [Related]
17. Monitoring of effects of cis-diamminedichloroplatinum II (Platidiam). Part II. Tests for mutagenic activity in the indicator system of Salmonella typhimurium his- strains (Ames test). Vancurová M; Procházková J; Srb V Neoplasma; 1985; 32(3):307-12. PubMed ID: 3895002 [TBL] [Abstract][Full Text] [Related]
18. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [TBL] [Abstract][Full Text] [Related]
19. Metabolic activation of 2-aminofluorene in the Salmonella mutagenicity assay by different S-9 preparations. Cantelli Forti G; Fracasso ME; Hrelia P; Leone R; Venturini MS; Guerra MC Arch Toxicol Suppl; 1984; 7():243-8. PubMed ID: 6393913 [TBL] [Abstract][Full Text] [Related]
20. [Metabolic activation of promutagens in the yeast-microsome test. II. Activation of cyclophosphamide and 2-aminofluorene]. Pavlov IuI; Khromov-Borisov NN Genetika; 1983 Mar; 19(3):362-74. PubMed ID: 6343182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]